Neutrophil recovery with or without G-CSF in non M3 AML patient with DA 3+7 protocol
Haematology Journal of Bangladesh
View Publication Info| Field | Value | |
| Title |
Neutrophil recovery with or without G-CSF in non M3 AML patient with DA 3+7 protocol
|
|
| Creator |
Islam, Gazi Yeasinul
Khan, Mohiuddin Ahmed Akter, Mafruha Rahman, H N Ashiqur Ibrahim, Md. Masud, Md. Adnan Hasan Farhad, Md. Nurul Rabby, A S M Tariqur |
|
| Subject |
neutrophil recovery
G-CSF non M3 AML DA 3 7 protocol |
|
| Description |
Background: Induction of acute myeloid leukaemia is associated with a high incidence of treatment related mortality mostly due to neutropenia related infections. This study primarily analyses the duration of neutrophil recovery with or without G-CSF during induction with DA 3+7 in non M3 AML patients. This study also evaluates role of G-CSF in duration febrile neutropenia, hospital stay, total blood products transfusion, total number of used injectable antibiotics and remission status. Methods: It was a Quasi Experimental - Non-Randomized Controlled Trail. There were two groups a) Case = Patients receiving G-CSF b) Control= Patients not receiving G-CSF. Sampling was purposive sampling. Results: 50 patients in two group, G-CSF group (n=25) and Control group (No G-CSF) (n=25) participated in this study. Among them 54% was female and 46% was male. Median age of the participants was 28 years. Neutrophil recovery duration in G-CSF group Vs Control group showed 22.64 Vs 24.64 days (p value 0.003). Duration of febrile neutropenia in G-CSF group Vs Control group showed 11.24 Vs 13.56 days (p value 0.038). Duration of hospital stay in G-CSF group Vs Control group showed 23.64 Vs 25.76 days (p value 0.002). Total number of blood and blood product transfusion in G-CSF group Vs Control group showed 3.80 Vs 3.88 (p value 0.597). Total number of injectable antibiotics in G-CSF group Vs Control group showed 2.72 Vs 3.12 days (p value 0.169). In G-CSF group 22 (88%) and in Control group 23 (92%) were in complete remission (p value 0.637). Conclusions: G-CSF significantly reduces the duration of neutropenia (p value 0.003), febrile neutropenia (p value 0.038) and hospital stay (p value 0.002) after induction with DA 3+7. This may cause reduction in treatment cost and sepsis related mortality. G-CSF can’t significantly reduce use of blood products (p value 0.597) and injectable antibiotics (p value 0.169) after induction with DA 3+7. G-CSF does not affect morphological remission status (p value 0.637) after induction with DA 3+7.
|
|
| Publisher |
Haematology Society of Bangladesh
|
|
| Date |
2021-05-06
|
|
| Type |
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion Peer-Reviewed Article |
|
| Format |
text/html
application/pdf |
|
| Identifier |
https://journal.hematologybd.org/index.php/haematoljbd/article/view/62
10.37545/haematoljbd202062 |
|
| Source |
Haematology Journal of Bangladesh; Vol. 5 No. 01 (2021); 15-19
2707-1405 2523-1219 |
|
| Language |
eng
|
|
| Relation |
https://journal.hematologybd.org/index.php/haematoljbd/article/view/62/185
https://journal.hematologybd.org/index.php/haematoljbd/article/view/62/195 |
|
| Rights |
Copyright (c) 2020 Gazi Yeasinul Islam, Mohiuddin Ahmed Khan, Mafruha Akter, H N Ashiqur Rahman, Md. Ibrahim, Md. Adnan Hasan Masud, Md. Nurul Farhad, A S M Tariqur Rabby
https://creativecommons.org/licenses/by-nc/4.0 |
|
